Evolocumab (Repatha), a human monoclonal antibody and proprotein convertase subtilisin/kexin type 9 inhibitor, produced positive results in persons living with HIV in the BEIJERINCK study by reducing their levels of low-density lipoprotein cholesterol (LDL-C). These individuals have a risk of cardiovascular disease that is almost twice that of HIV-negative individuals.
In the United States, diabetes mellitus is the most frequently reported condition among the 7162 coronavirus disease 2019 (COVID-19) cases for whom comorbidity data is available, according to new CDC information.
China’s biosimilar development engine is supercharged and running on octane, a recent report said.
New York hospitals face budget cuts totaling nearly $400 million; Ford Motor and General Electric announce plans to produce 50,000 ventilators in 100 days; federal judges deal setbacks to Republican governors hoping to claim abortion is a nonessential medical procedure amid the coronavirus disease 2019 (COVID-19) crisis.
The changes are aimed at helping hospitals increase their capacities for the sickest patients; expand the pool of local healthcare providers who are available to work; eliminating ordinary paperwork and documentation requirements; expanding Medicare coverage for respiratory-related devices and equipment for any medical reason; and expanding telehealth in Medicare by covering more than 80 additional services.
Psychiatric disorders can affect both the mind and the body. Anorexia nervosa is the most deadly of this type of disorder, despite its low incidence among both young men and women.
Disparities in funding exist between sickle cell disease (SCD) and cystic fibrosis, according to a study published in JAMA Network Open. For SCD, the disparities may be associated with decreased research productivity and novel drug development.
Long-term usage of immediate-release isradipine for treatment of Parkinson disease (PD) did not exhibit an effect on slowing the clinical progression of early-stage PD, according to study findings published today.
The reasons behind coronavirus disease 2019 (COVID-19) testing lags; FDA issues emergency authorization of malaria drugs for treatment of COVID-19; an expert from the University of Washington predicts that there could be at least 1 more extension of social distancing, beyond President Trump's announcement extending coronavirus guidelines to April 30.
Researchers at the University of British Columbia in Canada found eye movements may precede hand movements in certain actions that require a 2-step decision-making process, according to a study published in the Journal of Neurophysiology.
Researchers found patients with migraine were significantly more likely to report multiple comorbidities such as anxiety, insomnia, and depression, according to a study published in The Journal of Headache and Pain.
In a response to the coronavirus disease 2019 (COVID-19) pandemic, the American Society of Nephrology (ASN) has hosted series of webinars outlining CDC recommendations and policy changes for challenges in the dialysis setting.
Dapagliflozin is currently indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D). In the United States, it is also approved to reduce the risk of hospitalization for heart failure in patients with T2D and established cardiovascular (CV) disease or multiple CV risk factors.
Patients with certain inflammatory and senescence markers appeared to progress more quickly in their Parkinson disease, according to new research.
Patients with high-risk multiple myeloma tend to have significantly worse prognoses compared to those in the standard-risk category. A new study offers a potential solution.
A major study of patients with osteosarcoma suggests new pathogenic and likely pathogenic germline variants associated with the bone cancer.
Limited data about the effects of psoriasis therapy during pregnancy make it difficult to know which options are possible for pregnant patients and which ones can be harmful, according to a review.
Clinical trials for biosimilars and other agents are likely to slow down, if not stall, as coronavirus disease 2019 (COVID-19) wends its course, according to a UT Health expert.
Pregnancy complications that include preeclampsia, gestational hypertension, pre-term birth, and low birthweight serve as possible indicators for greater risk of heart failure in the long term, as indicated by change in global longitudinal strain on echocardiogram.
This week, the top managed care news includes a $2 trillion package to address economic damage from coronavirus heads to President Trump, a regulatory change could change the fortunes for biosimilars, and the world’s biggest cardiology meeting goes virtual.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An expert panel discussed the systemic and policy barriers to the uptake of biosimilars.
Ovarian cancer remains the most deadly of the gynecologic cancers. Researchers from Dana-Farber Cancer Institute may have discovered biomarkers that could predict which patients with platinum-resistant ovarian cancer would benefit from combination poly-ADP ribose polymerase (PARP) inhibitor/immune checkpoint inhibition treatment, as well as those who should pursue a different course of therapy.
Investigators used virtual reality to better understand the particular vision difficulties of patients with glaucoma.
Ibrutinib has been successful at fighting chronic lymphocytic leukemia (CLL), but new research finds interruptions in treatment with the drug can have a negative impact on patient outcomes.
A new study reveals severe depression in minority patients; Louisiana faces a surge of COVID-19 cases; New York state adjusts its medical workforce to combat rising cases.
Using a smartphone was associated with higher usage of acute medication, but less relief, in individuals with new-onset headache or increased severity of headache.
The bill includes $100 billion for hospitals; some are concerned that the bill, the Coronavirus Aid, Relief, and Economic Security (CARES) Act, does not go far enough, particularly for Medicaid.
According to the CDC, individuals with diabetes may experience more serious complications from the novel coronavirus (COVID-19) than the general population.
The FDA has accepted for filing with priority review Jazz Pharmaceuticals’ new drug application for JZP-258. The investigational medicine targets cataplexy and excessive daytime sleepiness associated with narcolepsy.